Pfizer, Johnson & Johnson Weigh on Pharmaceutical ETFs
April 18 2019 - 02:36PM
Dow Jones News
By Francesca Fontana
Pfizer Inc. (PFE) and Johnson & Johnson (JNJ) are trading at
the bottom of the Dow Jones Industrial Average Thursday, weighing
on exchange-traded funds with high exposure to the pharmaceutical
stocks.
Pfizer ranks among the top ten holdings at 21.2% in BlackRock's
iShares U.S. Pharmaceuticals ETF (IHE), according to ETF.com. IHE
tracks a broad-based, cap-weighted index of U.S. pharmaceutical
companies. Its other top holdings include Johnson & Johnson,
Elanco Animal Health Inc., and Allergan PLC.
IHE is trading lower during Thursday's session, falling
0.6%.
Johnson & Johnson ranks among the top ten holdings at 9.7%
in BlackRock's iShares Evolved U.S. Innovative Healthcare ETF
(IEIH). Per ETF.com, IEIH tracks an index that offers U.S.
pharmaceutical and biotechnology exposure. Its other top holdings
include Pfizer, Merck & Co., Celgene Corp., and Eli Lilly &
Co.
IEIH is trading lower, losing 0.9%.
Pfizer and Johnson & Johnson continue to lose ground as
investors weigh the impact of legislative proposals such as
Medicare for All. Pfizer shares fall 1.6% to $39.26, and Johnson
& Johnson shares fall 1.1% to $137.01.
(END) Dow Jones Newswires
April 18, 2019 15:21 ET (19:21 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Feb 2024 to Mar 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2023 to Mar 2024